Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...
This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...
C. neoformans is a fungal pathogen that causes meningitis, which causes approximately 180,000 deaths annually worldwide. Currently, AmB is the only fungicidal drug available to treat fungal meningitis ...
SSUCv3H4sIAAAAAAAEAIVSy27DIBC8V+o/WJxj1WDHxf2CXvoFUQ8YNjaKYyIMqarI/971g5SmUnJjZ2eH2cfl+SlJSC0GLclbcpkijHXX ...
There is hope in the fight against cryptococcal meningitis, the second leading cause of death in patients with advanced HIV (previously called AIDS), as scientists work around the clock to release new ...
In a recent study published in Nature Microbiology, researchers examined metabolite-drug-fungal interactions in the fungal meningitis pathogen Cryptococcus neoformans. Antibiotic resistance refers to ...
The encapsulated fungus Cryptococcus neoformans is the most common cause of fungal meningitis, with the highest rate of cryptococcosis found in AIDS patients. Despite antifungal treatment, ...
A ground-breaking UK study has demonstrated how Cryptococcus neoformans helps meningitis infection develop by blocking and bursting blood vessels, paving the way for new treatments in the future. In ...
MINNEAPOLIS/ST. PAUL (08/22/2023) —A team of University of Minnesota Medical School researchers successfully tested a new antifungal therapy to treat fungal meningitis. The trial results were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results